贾纳克斯治疗

最新新闻

• 评级变动
  Evercore Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/4/13
• 评级变动
  LifeSci Capital Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $60
  \u5e02\u573a\u8d44\u8baf · 2026/5/10
• 评级变动
  Guggenheim Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $68
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• 评级变动
  BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $29
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $24 to $68
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• 评级变动
  Evercore Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)
  TipRanks · 2026/6/25
• H.C. Wainwright Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
  TipRanks · 2026/10/1
• 评级变动
  JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/4/7
• 评级变动
  Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/4/28
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Janux Therapeutics Inc (JANX) and Progyny (PGNY)
  TipRanks · 2026/5/8
• 评级变动
  A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $55
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $58
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• William Blair Maintains Janux Therapeutics(JANX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• Wolfe Research Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/8/24
• 评级变动
  A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• Truist Financial Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Barclays Downgrades Janux Therapeutics(JANX.US) to Sell Rating, Cuts Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 评级变动
  Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/8/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。